BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8898228)

  • 1. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.
    Hayman AR; Jones SJ; Boyde A; Foster D; Colledge WH; Carlton MB; Evans MJ; Cox TM
    Development; 1996 Oct; 122(10):3151-62. PubMed ID: 8898228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tartrate-resistant acid phosphatase activity in tibial osteoclasts and cells elicited by ectopic bone and suture implants in normal and osteopetrotic rats.
    Walters LM; Schneider GB
    Bone Miner; 1988 Apr; 4(1):49-62. PubMed ID: 3056541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of matrix acid and alkaline phosphatases with mineralization of cartilage and endochondral bone.
    Roach HI
    Histochem J; 1999 Jan; 31(1):53-61. PubMed ID: 10405823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tartrate-resistant acid phosphatase knockout mice.
    Hayman AR; Cox TM
    J Bone Miner Res; 2003 Oct; 18(10):1905-7. PubMed ID: 14584904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tartrate-resistant acid phosphatase (TRAP) in long bone development.
    Blumer MJ; Hausott B; Schwarzer C; Hayman AR; Stempel J; Fritsch H
    Mech Dev; 2012 Jul; 129(5-8):162-76. PubMed ID: 22579636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
    Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
    J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
    Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
    Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
    Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
    Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
    Ortega N; Wang K; Ferrara N; Werb Z; Vu TH
    Dis Model Mech; 2010; 3(3-4):224-35. PubMed ID: 20142327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
    Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
    PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of osteoclastic bone resorption by mechanical stimulation in vitro.
    Klein-Nulend J; Veldhuijzen JP; van Strien ME; de Jong M; Burger EH
    Arthritis Rheum; 1990 Jan; 33(1):66-72. PubMed ID: 2302269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of endochondral ossification in the chick: chondrocyte apoptosis, bone formation by former chondrocytes, and acid phosphatase activity in the endochondral bone matrix.
    Roach HI
    J Bone Miner Res; 1997 May; 12(5):795-805. PubMed ID: 9144346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.
    Valverde P; Zhang J; Fix A; Zhu J; Ma W; Tu Q; Chen J
    J Bone Miner Res; 2008 Nov; 23(11):1775-88. PubMed ID: 18597627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.
    Minkin C
    Calcif Tissue Int; 1982 May; 34(3):285-90. PubMed ID: 6809291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight loading young chicks inhibits bone elongation and promotes growth plate ossification and vascularization.
    Reich A; Jaffe N; Tong A; Lavelin I; Genina O; Pines M; Sklan D; Nussinovitch A; Monsonego-Ornan E
    J Appl Physiol (1985); 2005 Jun; 98(6):2381-9. PubMed ID: 15677737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development.
    Rice DP; Kim HJ; Thesleff I
    Bone; 1997 Dec; 21(6):479-86. PubMed ID: 9430236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
    Dai XM; Zong XH; Akhter MP; Stanley ER
    J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast growth factor activity in medium conditioned by fetal rat bones.
    Scheven BA; Hamilton NJ; Duncan A; Robins SP
    Bone Miner; 1991 Sep; 14(3):221-35. PubMed ID: 1932894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.